High levels of serum fatty acids and hyperglycaemia (i.e. metabolic syndrome), as seen in T2D patients, can increase oxidative stress, which can damage endothelial cells and limit eNOS activity and NO bioavailability [60]. The gene discussed is NOS3; the disease is Hyperglycemia.